Author:
Schrama J.G.,Faneyte I.F.,Schornagel J.H.,Baars J.W.,Peterse J.L.,van de Vijver M.J.,Dalesio O.,van Tinteren H.,Rutgers E.J.T.,Richel D.J.,Rodenhuis S.
Reference37 articles.
1. Randomized phase III study of high-dose chemotherapy with cyclophosphamide thiotepa and carboplatin in operable breast cancer with 4 or more axillary lymph nodes;Rodenhuis;Proc Am Soc Clin Oncol,2000
2. Updated results of a prospective randomized comparison of two doses of combination alkylating agents (AA) as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes (LN) CALBG 9082 SWOG9114 NCIC MA-13;Peters;Proc Am Soc Clin Oncol,2001
3. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomized trial. Scandinavian Breast Cancer Group 9401 study;Bergh;Lancet,2000
4. Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma;Hortobagyi;J Natl Cancer Inst,2000
5. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph node involvement;Rodenhuis;Lancet,1998
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献